Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancerH Choy, H Safran, W Akerley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancerH Choy, W Akerley, H Safran, et al.
Cancer|August 22, 2000
p53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinomaT C King, W Akerley, A C Fan, et al.
Seminars in Radiation Oncology|April 21, 1999
Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junctionH Safran, P Akerman, W Cioffi, et al.
American Journal of Clinical Oncology|February 6, 2004
Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12Tyvin Rich, Jonathan Harris, R Abrams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancerH Choy, W Akerley, H Safran, et al.
Cancer|September 15, 1996
p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinomaH Safran, T King, H Choy, et al.
Cancer Investigation|April 9, 2001
Paclitaxel, cisplatin, and concurrent radiation for esophageal cancerH Safran, H Gaissert, P Akerman, et al.
Seminars in Radiation Oncology|April 21, 1999
Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV)H J Wanebo, P Chougule, N Ready, et al.
Investigational New Drugs|April 6, 2006
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxaneJ A Ajani, H Safran, C Bokemeyer, et al.
Pageof 4